Is a complete CELU research report available?

No complete published report is available for Celularity Inc. (CELU) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Celularity Inc. (CELU)

NASDAQ: CELU · USD

$0.93

+0.14 (+17.9%)· Recorded snapshot

Market cap	30.2M
Revenue (ttm)	18.7M
Net income (ttm)	-46.2M
EPS (ttm)	-$1.63
Shares out	32.5M
Volume	335,153
Beta	0.78

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 18.7M
Net income (ttm): -46.2M
EPS (ttm): -$1.63
Market cap: 30.2M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Conserver

Metric	Value
Amount currency	USD
CIK code	0001752828
Company name	Celularity Inc.
Country	United States
Country code	US
CUSIP number	151190204
Earnings date	2026-11-13
Earnings time	amc
Employees	115
Employees change	-8
Employees growth	-6.5%
Enterprise value	$99.5M
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	2016
Industry	Biotechnology
Is primary listing	Yes
Is SPAC	No
ISIN number	US1511902041
Last 10-K release date	2026-04-30
Last earnings date	2026-09-29
Last refreshed	2026-10-28
Last stock split date	2024-02-29
Last stock split type	Reverse
Market cap	$30.2M
Market cap category	Nano-Cap
Next earnings date	2026-11-10
Options	Yes
Price	$0.93
Price currency	USD
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-28
Symbol	CELU
U.S. state	New Jersey
Website	https://www.celularity.com

Metric

Value

Amount currency

USD

CIK code

0001752828

Company name

Celularity Inc.

Country

United States

Country code

CUSIP number

151190204

Earnings date

2026-11-13

Earnings time

amc

Employees

115

Employees change

-8

Employees growth

-6.5%

Enterprise value

$99.5M

Exchange

NASDAQ

Financial currency

USD

Financial report date

2026-06-30

First seen

2026-05-09

Fiscal year end

December

Founded

2016

Industry

Biotechnology

Is primary listing

Yes

Is SPAC

ISIN number

US1511902041

Last 10-K release date

2026-04-30

Last earnings date

2026-09-29

Last refreshed

2026-10-28

Last stock split date

2024-02-29

Last stock split type

Reverse

Market cap

$30.2M

Market cap category

Nano-Cap

Next earnings date

2026-11-10

Options

Yes

Price

$0.93

Price currency

USD

Sector

Healthcare

SIC code

2834

Stock price date

2026-10-28

Symbol

CELU

U.S. state

New Jersey

Website

https://www.celularity.com

Metric	Value
Earnings yield	-175.4%
EV/Sales	5.08x
FCF / EV yield	-9.4%
FCF yield	-34.8%
P/S ratio	1.37x
Sector forward P/E	23.56x
Sector P/E	50.13x

Metric

Value

Earnings yield

-175.4%

EV/Sales

5.08x

FCF / EV yield

-9.4%

FCF yield

-34.8%

P/S ratio

1.37x

Sector forward P/E

23.56x

Sector P/E

50.13x

Metric	Value
EBIT margin	-254.03%
EBITDA margin	-228.03%
Gross margin	19.23%
Operating margin	-254.03%
Pretax margin	-245.66%
Profit margin	-245.68%
Profit per employee	$-402,061
Profitable quarters	1
Revenue per employee	$162,313
ROA	-27.38%
ROA (5Y)	-21.8%
ROCE	-123.58%
ROIC	-140.98%
ROIC (5Y)	-86.63%
SBC / revenue	39.94%
Tax / revenue	0.02%

Metric

Value

EBIT margin

-254.03%

EBITDA margin

-228.03%

Gross margin

19.23%

Operating margin

-254.03%

Pretax margin

-245.66%

Profit margin

-245.68%

Profit per employee

$-402,061

Profitable quarters

Revenue per employee

$162,313

ROA

-27.38%

ROA (5Y)

-21.8%

ROCE

-123.58%

ROIC

-140.98%

ROIC (5Y)

-86.63%

SBC / revenue

39.94%

Tax / revenue

0.02%

Metric	Value
EPS growth (QoQ)	-6.97%
EPS growth quarters	1
EPS growth years	0
Gross profit growth	-85.39%
Gross profit growth (Q)	524.49%
Gross profit growth 5Y	-13.87%
Net income growth (QoQ)	-19.11%
Net income growth quarters	1
Net income growth years	0
Revenue growth	-58.14%
Revenue growth (Q)	-5.3%
Revenue growth (QoQ)	41.24%
Revenue growth 3Y	7.24%
Revenue growth 5Y	8.43%
Revenue growth years	0

Metric

Value

EPS growth (QoQ)

-6.97%

EPS growth quarters

EPS growth years

Gross profit growth

-85.39%

Gross profit growth (Q)

524.49%

Gross profit growth 5Y

-13.87%

Net income growth (QoQ)

-19.11%

Net income growth quarters

Net income growth years

Revenue growth

-58.14%

Revenue growth (Q)

-5.3%

Revenue growth (QoQ)

41.24%

Revenue growth 3Y

7.24%

Revenue growth 5Y

8.43%

Revenue growth years

Metric	Value
Depreciation and amortization	$4.9M
EBIT	$-47.4M
EBITDA	$-42.6M
EPS	$-1.63
FCF per share	$-0.27
Financing cash flow	$8.4M
Free cash flow	$-8.9M
Free cash flow minus SBC	$-16.4M
Gross profit	$3.6M
Income taxes	$3,000
Net borrowing	$5.2M
Net cash flow	$-542,000
Net income	$-46.2M
Operating cash flow minus SBC	$-16.4M
Operating income	$-47.4M
Revenue	$18.7M
Stock-based compensation	$7.5M

Metric

Value

Depreciation and amortization

$4.9M

EBIT

$-47.4M

EBITDA

$-42.6M

EPS

$-1.63

FCF per share

$-0.27

Financing cash flow

$8.4M

Free cash flow

$-8.9M

Free cash flow minus SBC

$-16.4M

Gross profit

$3.6M

Income taxes

$3,000

Net borrowing

$5.2M

Net cash flow

$-542,000

Net income

$-46.2M

Operating cash flow minus SBC

$-16.4M

Operating income

$-47.4M

Revenue

$18.7M

Stock-based compensation

$7.5M

Metric	Value
Altman Z-Score	-16.27
Book value per share	$-1.21
Goodwill	$7.3M
Interest coverage	-16.33
Long-term assets	$89.7M
Long-term liabilities	$72M
Net cash (debt)	$-69.2M
Net cash / market cap	-270.05%
Piotroski F-Score	2
Property, plant and equipment	$64.1M
Shareholders' equity	$-33.6M
Tangible book value	$-49.2M
Tangible book value per share	$-1.68
Total assets	$96.2M
Total cash	$586,000
Total debt	$69.8M
Total liabilities	$129.8M
WACC	4.69%

Metric

Value

Altman Z-Score

-16.27

Book value per share

$-1.21

Goodwill

$7.3M

Interest coverage

-16.33

Long-term assets

$89.7M

Long-term liabilities

$72M

Net cash (debt)

$-69.2M

Net cash / market cap

-270.05%

Piotroski F-Score

Property, plant and equipment

$64.1M

Shareholders' equity

$-33.6M

Tangible book value

$-49.2M

Tangible book value per share

$-1.68

Total assets

$96.2M

Total cash

$586,000

Total debt

$69.8M

Total liabilities

$129.8M

WACC

4.69%

Metric	Value
Asset turnover	0.17
Current assets	$6.4M
Current liabilities	$57.8M
Current ratio	0.11
Inventory turnover	5.88
Net working capital	$-38.7M
Quick ratio	0.09
Working capital	$-51.3M
Working capital turnover	-0.36

Metric

Value

Asset turnover

0.17

Current assets

$6.4M

Current liabilities

$57.8M

Current ratio

0.11

Inventory turnover

5.88

Net working capital

$-38.7M

Quick ratio

0.09

Working capital

$-51.3M

Working capital turnover

-0.36

Metric	Value
Buyback yield / dilution	-23.65%
Dividend yield	0%
Shareholder yield	-23.65%

Metric

Value

Buyback yield / dilution

-23.65%

Dividend yield

Shareholder yield

-23.65%

Metric	Value
150-day SMA	$1.03
1D price change	17.94%
1M price change	-39.57%
1M total return	-39.57%
1W price change	-33.82%
1W total return	-33.82%
1Y price change	-60.1%
1Y return CAGR	-60.13%
1Y total return	-60.1%
20-day SMA	$1.27
200-day SMA	$1.09
3M price change	11.04%
3M total return	11.04%
3Y price change	-60.1%
3Y return CAGR	-26.38%
3Y total return	-60.1%
50-day SMA	$1.31
50-day SMA vs 200-day SMA	50over200
52-week high	$2.55
52-week high date	2026-08-27
52-week low	$0.56
52-week low date	2026-06-30
5Y price change	-98.76%
5Y return CAGR	-58.47%
5Y total return	-98.76%
6M price change	-15.77%
6M total return	-15.77%
All-time high	$134.00
All-time high date	2021-07-20
All-time low	$0.56
All-time low date	2026-06-30
Average true range (ATR)	$0.16
Average volume	152.5K
Beta (1Y)	1.86
Beta (2Y)	3.36
Beta (5Y)	0.78
Change from 52-week high	-63.45%
Change from 52-week low	66.4%
Change from all-time high	-99.38%
Change from all-time low	48.88%
Change from open	15.95%
Day's gap	1.72%
Dollar volume	$312,363
High price	$1.01
Low price	$0.79
Monthly RSI	36.25
Open price	$0.80
Position in 52-week range	64.38%
Premarket change	6.33%
Premarket close	$0.79
Premarket price	$0.84
Previous close	$0.79
Price vs 150-day SMA	-19.2%
Price vs 20-day SMA	-34.29%
Price vs 200-day SMA	-23.57%
Price vs 50-day SMA	-36.54%
Relative volume	2.2
RSI	34.94
Sharpe ratio	0.02
Sharpe ratio (3Y)	0.37
Sharpe ratio (5Y)	-0.09
Sortino ratio	0.09
Sortino ratio (3Y)	0.82
Sortino ratio (5Y)	-0.11
Volume	335.2K
Weekly RSI	41.84
YTD price change	-24.87%
YTD total return	-24.87%

Metric

Value

150-day SMA

$1.03

1D price change

17.94%

1M price change

-39.57%

1M total return

-39.57%

1W price change

-33.82%

1W total return

-33.82%

1Y price change

-60.1%

1Y return CAGR

-60.13%

1Y total return

-60.1%

20-day SMA

$1.27

200-day SMA

$1.09

3M price change

11.04%

3M total return

11.04%

3Y price change

-60.1%

3Y return CAGR

-26.38%

3Y total return

-60.1%

50-day SMA

$1.31

50-day SMA vs 200-day SMA

50over200

52-week high

$2.55

52-week high date

2026-08-27

52-week low

$0.56

52-week low date

2026-06-30

5Y price change

-98.76%

5Y return CAGR

-58.47%

5Y total return

-98.76%

6M price change

-15.77%

6M total return

-15.77%

All-time high

$134.00

All-time high date

2021-07-20

All-time low

$0.56

All-time low date

2026-06-30

Average true range (ATR)

$0.16

Average volume

152.5K

Beta (1Y)

1.86

Beta (2Y)

3.36

Beta (5Y)

0.78

Change from 52-week high

-63.45%

Change from 52-week low

66.4%

Change from all-time high

-99.38%

Change from all-time low

48.88%

Change from open

15.95%

Day's gap

1.72%

Dollar volume

$312,363

High price

$1.01

Low price

$0.79

Monthly RSI

36.25

Open price

$0.80

Position in 52-week range

64.38%

Premarket change

6.33%

Premarket close

$0.79

Premarket price

$0.84

Previous close

$0.79

Price vs 150-day SMA

-19.2%

Price vs 20-day SMA

-34.29%

Price vs 200-day SMA

-23.57%

Price vs 50-day SMA

-36.54%

Relative volume

2.2

RSI

34.94

Sharpe ratio

0.02

Sharpe ratio (3Y)

0.37

Sharpe ratio (5Y)

-0.09

Sortino ratio

0.09

Sortino ratio (3Y)

0.82

Sortino ratio (5Y)

-0.11

Volume

335.2K

Weekly RSI

41.84

YTD price change

-24.87%

YTD total return

-24.87%

Metric	Value
Float	22.4M
Float percentage	68.95%
Shares change (QoQ)	-3.15%
Shares change (YoY)	23.65%
Shares held by insiders	10.92%
Shares held by institutions	11.7%
Shares outstanding	32.5M
Short % of float	1.75%
Short % of shares	1.21%
Short ratio	0.9 days

Metric

Value

Float

22.4M

Float percentage

68.95%

Shares change (QoQ)

-3.15%

Shares change (YoY)

23.65%

Shares held by insiders

10.92%

Shares held by institutions

11.7%

Shares outstanding

32.5M

Short % of float

1.75%

Short % of shares

1.21%

Short ratio

0.9 days

Celularity Inc. (CELU)

Price

Financial snapshot

Fair-value bridge

Latest news · CELU

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All CELU indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on CELU

Frequently asked questions